$PTLA $26.99 I have been buying on the pullback on this one. Today I sold a tranche to rightsize my position as it runs to it's catalyst. This one is looking strong on a down Bio Market day. PDUFA August 21 under priority review for BLA seeking FDA approval to reverse the blood thinning activity.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.